←Back to Expert Scholars
Translational Medicine / 转化医学Pembrolizumab Clinical Development
Eric Rubin
MD
🏢Merck Research Laboratories🌐USA
Senior Vice President, Global Clinical Development
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Eric Rubin directs oncology clinical development at Merck and has helped steer pembrolizumab development across multiple tumor types. He is a longstanding investigator in early phase oncology drug development and biomarker integration.
Share:
🧪Research Fields 研究领域
oncology clinical development
pembrolizumab indications
phase I trials
biomarker development
regulatory science
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Eric Rubin 的研究动态
Follow Eric Rubin's research updates
留下邮箱，当我们发布与 Eric Rubin（Merck Research Laboratories）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment